Catabasis Pharmaceuticals, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Catabasis Pharmaceuticals, Inc.
Quantité totale PI 36
Rang # Quantité totale PI 40 319
Note d'activité PI 0,4/5.0    1
Rang # Activité PI 962 919
Symbole boursier CATB (nasdaq)
ISIN US14875P2065
Capitalisation 25.40M  (USD)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

7 0
0 0
29 0
0
 
Dernier brevet 2021 - Fatty acid acetylated salicylate...
Premier brevet 2009 - Fatty acid acetylated salicylate...

Derniers inventions, produits et services

2020 Invention Fatty acid acetylated salicylates and their uses. The invention relates to Fatty Acid Acetylated...
2019 Invention Fatty acid cysteamine conjugates and their use as activators of autophagy. The invention relates...
2018 Invention Edasalonexent dosing regimen for treating muscular dystrophy. The invention provides methods and...
Invention Edasalonexent dosing regimen for treating muscular dystrophy. e.g.e.ge.g., edasalonexent, effecti...
Invention Combination therapies for treating muscular dystrophy. The present disclosure relates to methods...
Invention Combination therapies for treating muscular dystrophy. The present disclosure relates to methods ...
2017 Invention Fatty acid cysteine-based conjugates and their use in treating medical disorders. The invention ...
Invention Fatty acid niacin conjugates and their uses. The invention relates to fatty acid niacin conjugat...
2016 Invention Fatty acid amides, compositions and methods of use. The invention relates to fatty acid amides; ...
Invention Methods of lowering proprotein convertase subtilisin/kexin type 9 (pcsk9). The invention relates...
Invention Fatty acid fumarate derivatives and their uses. The invention relates to Fatty Acid Fumarate Der...
Invention Fatty acid antiviral conjugates and their uses. The invention relates to fatty acid antiviral co...
2015 Invention Fatty acid cox inhibitor derivatives and their uses. The invention relates to fatty acid COX inh...
Invention Fatty acid cysteamine conjugates and their use as activators of autophagy. The invention relates ...
Invention Fatty acid cysteamine conjugates of cftr modulators and their use in treating medical disorders. ...
Invention Fatty acid acylated salicylates and their uses. The invention relates to fatty acid acylated sali...
Invention Fatty acid conjugates of statin and fxr agonists: compositions and methods of use. The invention...
Invention Fatty acid niacin conjugates and their uses. The invention relates to fatty acid niacin conjugate...
Invention Fatty acid fumarate derivatives and their uses. The invention relates to Fatty Acid Fumarate Deri...
Invention Niacin conjugated fatty acid mixtures and their uses. The invention relates to niacin conjugated ...
2014 Invention Fatty acid niacin conjugates. The invention provides fatty acid niacin conjugates; pharmaceutica...
Invention Fatty acid niacin conjugates. The invention provides fatty acid niacin conjugates; pharmaceutical...
Invention Fatty acid anticancer derivatives and their uses. The invention relates to fatty acid anticancer ...
Invention Fatty acid acetylated salicylates and their uses. The invention relates to Fatty Acid Acetylated ...
Invention Use of fatty acid niacin conjugates for treating diseases. The invention relates to fatty acid n...
Invention Use of fatty acid niacin conjugates for treating diseases. The invention relates to fatty acid ni...
2013 Invention Methods of lowering proprotein conversate subtilisin/kexin type 9 (pcsk9). The invention relates...
Invention Methods of lowering proprotein convertase subtilisin/kexin type 9 (pcsk9). The invention relates ...
Invention Fatty acid conjugates of statin and fxr agonists; compositions and method of uses. The invention ...
2012 Invention Use of intracellular enzymes for the release of covalently linked bioactives. The present invent...
2011 Invention Bis-fatty acid conjugates and their uses. The invention relates to bis-fatty acid conjugates; co...